Civic Intelligence

Nf2 Biosolutions

990 • Fiscal year 2018 • EIN 83-0940046

Jan 01, 2018 to Dec 31, 2018

West Chester, PA
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

57th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2018 filings • 501(c)3 • <$500k nonprofits • Source year 2018

Liabilities / Revenue

56th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2018 filings • 501(c)3 • <$500k nonprofits • Source year 2018

Net Margin

98th percentile

94%

Higher net margin than 98% of similar nonprofits.

2018 filings • 501(c)3 • <$500k nonprofits • Source year 2018

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2018

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2018

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2018

Assets

$121,602

No earlier filing loaded for comparison.

Net Assets

$121,602

No earlier filing loaded for comparison.

Liabilities

$0

No earlier filing loaded for comparison.

Revenue

$129,439

No earlier filing loaded for comparison.

Expenses

$7,837

No earlier filing loaded for comparison.

Net Income

$121,602

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$1.0M$500K$0Assets 2018: $121,602Liabilities 2018: $0Net Assets 2018: $121,6022018Assets 2019: $365,085Liabilities 2019: $0Net Assets 2019: $365,0852019Assets 2020: $638,177Liabilities 2020: $101,900Net Assets 2020: $536,2772020Assets 2021: $796,187Liabilities 2021: $101,900Net Assets 2021: $694,2872021Assets 2022: $906,470Liabilities 2022: $101,900Net Assets 2022: $804,5702022Assets 2023: $712,390Liabilities 2023: $101,900Net Assets 2023: $610,4902023Assets 2024: $621,589Liabilities 2024: $101,900Net Assets 2024: $519,6892024

Highlighted filing

2018

Assets$121,602
Liabilities$0
Net Assets$121,602

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.0M$500K$0-$500KRevenue 2018: $129,439Expenses 2018: $7,837Net Income 2018: $121,6022018Revenue 2019: $449,651Expenses 2019: $206,168Net Income 2019: $243,4832019Revenue 2020: $708,384Expenses 2020: $537,191Net Income 2020: $171,1932020Revenue 2021: $544,244Expenses 2021: $386,234Net Income 2021: $158,0102021Revenue 2022: $418,620Expenses 2022: $308,337Net Income 2022: $110,2832022Revenue 2023: $772,336Expenses 2023: $966,416Net Income 2023: -$194,0802023Revenue 2024: $226,008Expenses 2024: $316,809Net Income 2024: -$90,8012024

Highlighted filing

2018

Revenue$129,439
Expenses$7,837
Net Income$121,602
Filing Detail Status

This 2018 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2018 to Dec 31, 2018
Mission and Program Overview

Mission

Seeking a cure or preventative treatment for nf2 by vigorously supporting and advancing existing and next generation biomedical technologies such as gene transfer therapy and immunontherapy

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Peer Organizations

Similar nonprofits based on the same Siviq industry and scale cohort. 2018 filings • 501(c)3 • <$500k nonprofits